Table 2. . Study treatment.
Treatment characteristics | Variable | n (all 56 pts) | % of pts |
---|---|---|---|
Chemo regimen | Gemcitabine alone | 4 | 7 |
Carboplatin/gemcitabine | 12 | 21 | |
Cisplatin/gemcitabine | 40 | 72 | |
Number of cycles | Six cycles | 17 | 30 |
Five cycles | 3 | 5 | |
Four cycles | 25 | 45 | |
Less than four cycles | 11 | 20 | |
Progression after first-line treatment | 40 | 71 | |
Treatment after progression | Second-line chemotherapy | 19 | 34 |
Third-line chemotherapy | 6 | 11 | |
Palliative RT† | All | 14 | 27 |
Bone | 7 | 14 | |
Brain | 5 | 10 | |
Mediastinum (SVCO) | 2 | 4 |
†Only stage IV were treated with palliative RT.
Pts: Pts; RT: Radiotherapy; SVCO: Superior vena cava obstruction.